Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening-Reference-Cited by-同舟云学术

Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening

Published:2021-10-19 Issue: Volume: Page:
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Hu Xue-ping,Yang Liu,Chai Xin,Lei Yi-xuan,Alam Md Shah,Liu Lu,Shen Chao,Jiang De-jun,Wang Zhe,Liu Zhi-yong,Xu Lei,Wan Kang-lin,Zhang Tian-yu,Yin Yue-lan,Li Dan,Cao Dong-sheng,Hou Ting-jun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-021-00779-1.pdf

Reference48 articles.

1. WHO, Global Tuberculosis Report 2020. Geneva: World Health Organization. 2020, Licence: Cc by-Nc-Sa 3.0 Igo.

2. Balganesh TS, Alzari PM, Cole ST. Rising standards for tuberculosis drug development. Trends Pharmacol Sci. 2008;29:576–81.

3. Pietersen E, Ignatius E, Streicher EM, Mastrapa B, Padanilam X, Pooran A, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet. 2014;383:1230–9.

4. Zhang MW, Zhou L, Zhang Y, Chen B, Peng Y, Wang F, et al. Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. Eur J Med Res. 2021;26:31.

5. Manina G, Pasca MR, Buroni S, De Rossi E, Riccardi G. Decaprenylphosphoryl-beta-D-ribose 2 ‘-epimerase from Mycobacterium Tuberculosis is a magic drug target. Curr Med Chem. 2010;17:3099–108.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore mapping, 3D QSAR, molecular docking, and ADME prediction studies of novel Benzothiazinone derivatives;In Silico Pharmacology;2024-08-29

2. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches;Drug Discovery Today;2024-06

3. Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis;Journal of Medicinal Chemistry;2024-01-17

4. Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential;Pharmaceuticals;2023-11-06

5. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review;Journal of Biomolecular Structure and Dynamics;2023-07-03